Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pacific Edge Limited ( (PFGTF) ) has shared an update.
Pacific Edge Limited has announced the quotation of 160,728,498 ordinary fully paid foreign exempt securities on the ASX, effective August 13, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially impacting its operational dynamics and stakeholder interests positively.
More about Pacific Edge Limited
Pacific Edge Limited operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests for the early detection and management of cancer. The company is known for its innovative solutions in cancer diagnostics, primarily targeting the global healthcare market.
For an in-depth examination of PFGTF stock, go to TipRanks’ Overview page.